An artificial intelligence model predicts how brain immune cells react to RNA and DNA nanoparticles, helping scientists design safer and more effective nucleic acid therapies faster.

The developers of OpenFold3 have released an early version of the tool, which they hope will one day perform on par with DeepMind’s protein-structure model.

According to a tweet by Applied DNA Sciences (@BNBX_Corp), the company expects its combined BNB holdings to exceed $17 ...

A study reveals the secrets behind the rodent’s remarkable ability to live 10 times longer than expected, without cancer or ...

A study reveals that a protein called RPA is essential for maintaining chromosome stability by stimulating telomerase. New findings from the-Madison suggest that problems with a key protein that helps ...

Every modern automobile carries a 17-character vehicle identification number, an alphanumeric string unique to that single ...

From designing proteins not found in nature to extending healthy lifespan, Retro Biosciences is applying AI models to advance cellular reprogramming for aging research. The company operates across ...

The Welsh Rugby Union (WRU) has announced a landmark decision on the future of elite rugby in Wales, following one of the ...

Inside KAL Solutions Group in Forbes Romania ✅ Afla cele mai noi informatii din sfera BrandVoice ✅ Stiri si evenimente de ...

Why Some People Are Born to Be Afraid Scientists are discovering that our tendency to develop certain phobias might be ...

NEW YORK, NY / ACCESS Newswire / October 23, 2025 / There are two kinds of tightening in business. The kind you do because you have to, and the kind you do because you’re getting ready to move faster.